Events

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy
In the last few years, at least two different meta-analyses have suggested that newer estrogen-lowering aromatase inhibitors used to prevent recurrence of breast cancer may increase the risk of developing cardiovascular disease. But a study published ... [...]
5
Like
Save
ASCO GU 2016 More CNS Events With Enzalutamide Vs. Bicalutamide Treatment of …
San Francisco, CA USA (UroToday.com) Among men with metastatic castration resistant prostate cancer (mCRPC) who were initiated on enzalutamide or bicalutamide treatment, more central nervous system (CNS) events occurred with enzalutamide, even ... [...]
4
Like
Save